Compare Tilray Brands Inc (TLRY) vs Vicor Corporation Common Stock (VICR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tilray Brands Inc vs Vicor Corporation Common Stock — how do they compare? Tilray Brands Inc trades at $3.06 (market cap $463.31M), while Vicor Corporation Common Stock trades at $232 (market cap $11.31B). The key difference: Vicor Corporation Common Stock is far larger — about 24.4× Tilray Brands Inc's market cap, and Vicor Corporation Common Stock is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tilray Brands Inc for 31 Days and Vicor Corporation Common Stock for 0 Days on average.
| TLRY | VICR | |
|---|---|---|
Market Cap | $463.31M | $11.31B |
Volume | 4,627,093 | 809,713 |
Sector | Health | Technology |
52-Week High | $16.80 | $379.78 |
52-Week Low | $3.14 | $57.31 |
Typical Hold Time | 31 Days | 0 Days |
Enterprise Value | $617.23M | $10.87B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TLRY trades at $3.27, down 2.68% on the day and near 52-week lows, reflecting persistent bearish pressure. The stock's technical indicators are mixed but overall signal remains negative. Fundamentally, the company reported a net loss of $2.19 billion in 2025 despite $821 million in revenue, with profitability metrics deeply negative. Recent news highlights continued stock weakness and strategic brand expansions under Tilray ownership.
The outlook is highly speculative; TLRY faces significant execution and profitability challenges, though analyst consensus suggests substantial upside potential from current levels. Key risks include ongoing losses, high debt levels, and regulatory uncertainty in the cannabis sector. Investment suitability is limited to high-risk tolerance investors betting on a operational turnaround or favorable regulatory shifts.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →About Vicor Corporation Common Stock
Vicor Corporation designs, manufactures, and markets modular power components and complete power systems, serving high-performance computing, data center, industrial, automotive, and aerospace and defense markets.
Read more on VICR →
